GleamWall
中文EN

KBLB Kraig Biocraft Laboratories, Inc.

Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) · OTC · SEC CIK 1413119 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-5.3%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-127.4%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets300.7%
Debt / equity—
Current ratio0.27x
Interest coverage-5.67x

Cash quality & payout

Operating cash flow / net income0.56x
Accruals ratio-56.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$3,000———————
Cost of revenue$4,320———————
Gross profit-$1,320———————
R&D expense$132,284$64,369$66,701$68,751$9,243$63,888$23,876$60,557
SG&A expense$752,243$374,381$495,566$105,927$1.20M$344,035$308,851$280,174
Operating income-$1.14M-$703,433-$825,500-$722,668-$1.43M-$637,745-$580,492-$715,916
Interest expense$153,385$151,399$148,433$144,120$144,255$141,986$140,348$135,890
Pretax income-$1.24M-$909,535-$942,720-$787,621-$1.51M-$726,133-$600,033-$851,675
Net income-$1.24M-$909,535-$942,720-$787,621-$1.51M-$726,133-$600,033-$851,675
EBITDA-$1.13M-$696,331-$819,278-$715,066-$1.43M-$631,908-$574,809-$709,864
EPS (basic)0.000.000.00—0.000.000.00—
EPS (diluted)0.000.000.00—0.000.000.00—
Weighted avg. shares (diluted)1.12B1.11B1.09B—1.07B1.05B1.04B—
Balance sheet
Cash & equivalents$2.78M$3.39M$2.89M$1.79M$1.57M$785,462$397,001$673,264
Short-term investments$0$0$0$0$0$0$0$0
Inventory$172,761$134,142$74,307$29,067$29,067$6,884$6,884$6,884
Current assets$3.02M$3.57M$3.01M$1.87M$1.64M$838,975$452,714$740,285
PP&E, net$62,621$54,403$32,897$25,003$30,993$36,984$39,038$44,721
Total assets$3.74M$4.27M$3.72M$2.57M$2.36M$1.59M$1.32M$1.51M
Current liabilities$11.13M$10.90M$10.68M$10.45M$10.18M$10.03M$9.83M$9.61M
Total liabilities$11.24M$11.02M$10.78M$10.56M$10.31M$10.06M$9.86M$9.65M
Shareholders' equity-$7.50M-$6.75M-$7.06M-$8.00M-$7.96M-$8.47M-$8.55M-$8.15M
Cash flow statement
Operating cash flow-$594,182-$598,695-$529,718-$449,487-$461,859-$443,125-$434,499-$512,523
Capital expenditure$13,662$28,608$14,116$1,612$0———
Free cash flow-$607,844-$627,303-$543,834-$451,099-$461,859———
Investing cash flow-$13,662-$28,608-$14,116$71,833$222,754———
Financing cash flow$0$1.13M$1.64M$602,198$1.02M$688,131$158,236$0
Depreciation & amortization$5,444$7,102$6,222$7,602$5,992$5,837$5,683$6,052
Stock-based compensation$29,115$29,085$29,085$29,095$29,095———

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.